HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hai Zhang Selected Research

sini tang

9/2016Cardiovascular Disease Chemogenomics Knowledgebase-guided Target Identification and Drug Synergy Mechanism Study of an Herbal Formula.
7/2015Comparative pharmacokinetics of three monoester-diterpenoid alkaloids after oral administration of Acontium carmichaeli extract and its compatibility with other herbal medicines in Sini Decoction to rats.
12/2014Investigation of the therapeutic effectiveness of active components in Sini decoction by a comprehensive GC/LC-MS based metabolomics and network pharmacology approaches.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hai Zhang Research Topics

Disease

60Neoplasms (Cancer)
02/2022 - 01/2009
23Inflammation (Inflammations)
01/2022 - 10/2008
22Hepatocellular Carcinoma (Hepatoma)
09/2020 - 01/2009
15Infections
01/2021 - 08/2009
9Obesity
11/2018 - 10/2008
9Liver Neoplasms (Liver Cancer)
01/2018 - 03/2013
8Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 06/2016
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 08/2015
8Cardiovascular Diseases (Cardiovascular Disease)
06/2018 - 12/2014
7Body Weight (Weight, Body)
01/2022 - 02/2011
7Neoplasm Metastasis (Metastasis)
01/2021 - 01/2009
7Tuberculosis (Tuberculoses)
09/2015 - 07/2006
6Fibrosis (Cirrhosis)
01/2022 - 06/2017
6Liver Diseases (Liver Disease)
01/2022 - 05/2009
6Heart Failure
07/2020 - 05/2014
6Autoimmune Diseases (Autoimmune Disease)
01/2020 - 01/2014
6Adenocarcinoma of Lung
01/2020 - 10/2016
6Carcinogenesis
01/2019 - 06/2013
5Breast Neoplasms (Breast Cancer)
11/2020 - 06/2014
5Insulin Resistance
11/2018 - 02/2011
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2018
4Hypertension (High Blood Pressure)
01/2022 - 09/2013
4Mitochondrial Diseases (Mitochondrial Disease)
07/2019 - 02/2015
4Hypoxia (Hypoxemia)
06/2019 - 07/2011
4Coronary Disease (Coronary Heart Disease)
12/2018 - 08/2014
4Parkinson Disease (Parkinson's Disease)
02/2016 - 07/2007
4Glucose Intolerance
01/2013 - 10/2008
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2012
3Pneumonia (Pneumonitis)
07/2021 - 11/2018
3Lung Neoplasms (Lung Cancer)
10/2020 - 11/2013
3Lung Injury
10/2020 - 01/2019
3Atherosclerosis
04/2020 - 05/2017
3Poisoning
01/2017 - 11/2015
3Dyskinesias (Dyskinesia)
07/2011 - 07/2007
2Hematologic Neoplasms (Hematological Malignancy)
02/2022 - 01/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 01/2020
2Hyperlipidemias (Hyperlipidemia)
01/2022 - 12/2014
2Chronic Obstructive Pulmonary Disease (COPD)
12/2021 - 01/2019
2Fatigue
09/2021 - 12/2010
2Spontaneous Abortion (Miscarriage)
08/2021 - 04/2021
2Asthma (Bronchial Asthma)
01/2021 - 06/2014
2Virus Diseases (Viral Diseases)
12/2020 - 08/2019

Drug/Important Bio-Agent (IBA)

32Proteins (Proteins, Gene)FDA Link
12/2021 - 07/2006
13Pharmaceutical PreparationsIBA
10/2021 - 11/2009
11Biomarkers (Surrogate Marker)IBA
12/2021 - 06/2013
10Therapeutic UsesIBA
01/2021 - 01/2013
9Dinoprostone (PGE2)FDA Link
08/2015 - 01/2009
8CytokinesIBA
02/2022 - 05/2012
6Sirolimus (Rapamycin)FDA Link
01/2020 - 12/2011
6B-Cell Activating FactorIBA
01/2020 - 01/2014
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 05/2014
6ProstaglandinsIBA
08/2015 - 01/2009
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2016
5CadmiumIBA
01/2020 - 08/2015
4schizandrin BIBA
01/2022 - 01/2017
4p38 Mitogen-Activated Protein KinasesIBA
01/2022 - 06/2017
4Capsules (Microcapsules)IBA
01/2022 - 01/2018
4Messenger RNA (mRNA)IBA
12/2021 - 09/2014
4RNA (Ribonucleic Acid)IBA
12/2021 - 09/2014
4Carbon Tetrachloride (Tetrachloromethane)IBA
10/2021 - 01/2017
4AntibodiesIBA
01/2021 - 08/2011
4Peptides (Polypeptides)IBA
07/2020 - 08/2009
4Phosphotransferases (Kinase)IBA
01/2020 - 11/2012
4LipopolysaccharidesIBA
08/2019 - 03/2016
4Small Interfering RNA (siRNA)IBA
01/2019 - 05/2017
4Coloring Agents (Dyes)IBA
01/2018 - 08/2016
4Glucose (Dextrose)FDA LinkGeneric
03/2016 - 07/2011
3Chimeric Antigen ReceptorsIBA
02/2022 - 01/2019
3AlkaloidsIBA
01/2022 - 01/2011
3AntigensIBA
01/2022 - 10/2011
3Particulate MatterIBA
07/2021 - 01/2019
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2021 - 01/2010
3Drug CarriersIBA
08/2020 - 05/2017
3Long Noncoding RNAIBA
01/2020 - 11/2018
3InflammasomesIBA
01/2020 - 11/2018
3ErbB Receptors (EGF Receptor)IBA
08/2019 - 01/2019
3TabletsIBA
12/2018 - 09/2013
3YangxinshiIBA
06/2018 - 03/2018
3VaccinesIBA
03/2018 - 01/2012
3NF-kappa B (NF-kB)IBA
01/2018 - 10/2008
3CarbocyaninesIBA
01/2018 - 08/2016
3Insulin (Novolin)FDA Link
01/2018 - 10/2008
3Lipoprotein(a)IBA
11/2017 - 08/2016
3salinomycinIBA
05/2017 - 01/2016
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017 - 09/2015
3sini tangIBA
09/2016 - 12/2014
3Levodopa (L Dopa)FDA LinkGeneric
07/2011 - 07/2007
2LignansIBA
01/2022 - 01/2017
2squamous cell carcinoma-related antigenIBA
01/2022 - 10/2020
2LipidsIBA
01/2022 - 12/2014
2Flame Retardants (Fire Retardants)IBA
08/2021 - 04/2021
2OrganophosphatesIBA
08/2021 - 04/2021
2Chloroquine (Aralen)FDA LinkGeneric
11/2020 - 01/2016

Therapy/Procedure

27Therapeutics
02/2022 - 06/2014
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 06/2018
4Transplantation
01/2019 - 12/2013
3Drug Therapy (Chemotherapy)
01/2022 - 06/2010
3Radiotherapy
08/2021 - 10/2010
2Punctures
01/2022 - 03/2016
2Thyroidectomy
01/2022 - 08/2018